Boc-L-cysteine,
N-tert-butyloxycarbonylcysteine,
Boc-Cys-OH,
20887-95-0,
Boc-L-cysteine,
N-Boc-L-Cysteine,
N-tert-Butyloxycarbonylcysteine,
(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-MERCAPTOPROPANOIC ACID,
N-ALPHA-T-BUTYLOXYCARBONYL-L-CYSTEINE,
n-t-butyloxycarbonyl-l-cysteine,
(2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-sulfanylpropanoic acid,
L-Cysteine, N-((1,1-dimethylethoxy)carbonyl)-,
L-Cysteine, N-[(1,1-dimethylethoxy)carbonyl]-,
n-boc-cysteine,
PubChem9978,
BOC-L-CYS-OH,
N-t-butoxycarbonyl-L-cysteine,
SCHEMBL314569,
AC1L484R,
CTK4E5391,
DTXSID30175033,
ATVFTGTXIUDKIZ-YFKPBYRVSA-N,
BCP06688,
ZINC4521267,
ANW-24273,
MFCD00065565,
N-(tert-Butyloxycarbonyl)-L-cysteine,
AKOS015841311,
AKOS015895914,
AB02619,
FCH3646409,
AJ-51390,
AK-81101,
AS-49016,
SC-02387,
N-(TERT-BUTOXYCARBONYL)-L-CYSTEINE,
AB1006954,
AX8005480,
TC-066670,
FT-0082162,
FT-0602024,
ST51012423,
X5792,
B-7812,
L-Cysteine,N-[(1,1-dimethylethoxy)carbonyl]-,
887B950,
Boc-Cys-OH, for chiral derivatization, >=98.5%,
C-25172,
I06-1373,
J-013702,
(R)-2-(tert-butoxycarbonylamino)-3-mercaptopropanoic acid,
(2R)-2-[(tert-butoxy)carbonylamino]-3-sulfanylpropanoic acid,
(2R)-2-{[(tert-butoxy)carbonyl]amino}-3-sulfanylpropanoic acid,
(R)-2-TERT-BUTOXYCARBONYLAMINO-3-MERCAPTO-PROPIONIC ACID,
C8H15NO4S,
CID152319,
ACN-033113,
CB10565,
Boc-L-cysteine, 98%, for chiral derivatization - 250MG 250mg,